Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance, beginning at Sep. 30, 2019 $ 1,708 $ 36,201,758 $ (26,174,082) $ 10,029,384
Balance, beginning, shares at Sep. 30, 2019 17,077,873      
Stock-based compensation expense   4,054,351   4,054,351
Issuance of common stock, net of issuance costs $ 604 33,283,366   33,283,970
Issuance of common stock, net of issuance costs (in shares) 6,037,500      
Issuance of restricted stock for services (in shares) 4,823      
Net loss     (12,683,708) (12,683,708)
Balance, ending at Jun. 30, 2020 $ 2,312 73,539,475 (38,857,790) 34,683,997
Balance, ending, shares at Jun. 30, 2020 23,120,196      
Balance, beginning at Mar. 31, 2020 $ 1,708 39,045,394 (35,057,902) 3,989,200
Balance, beginning, shares at Mar. 31, 2020 17,080,625      
Stock-based compensation expense   1,210,715   1,210,715
Issuance of common stock, net of issuance costs $ 604 33,283,366   33,283,970
Issuance of common stock, net of issuance costs (in shares) 6,037,500      
Issuance of restricted stock for services (in shares) 2,071      
Net loss     (3,799,888) (3,799,888)
Balance, ending at Jun. 30, 2020 $ 2,312 73,539,475 (38,857,790) 34,683,997
Balance, ending, shares at Jun. 30, 2020 23,120,196      
Balance, beginning at Sep. 30, 2020 $ 2,315 74,850,935 (43,558,602) $ 31,294,648
Balance, beginning, shares at Sep. 30, 2020 23,154,084     23,154,084
Stock-based compensation expense   2,743,875   $ 2,743,875
Issuance of common stock, net of issuance costs $ 920 42,615,456   42,616,376
Issuance of common stock, net of issuance costs (in shares) 9,200,000      
Issuance of common stock, Vera acquisition $ 31 1,759,189   1,759,220
Issuance of common stock, Vera acquisition (in shares) 308,635      
Issuance of restricted stock for services (in shares) 7,056      
Exercise of stock options $ 5 112,441   $ 112,446
Exercise of stock options (in shares) 47,052     47,052
Net loss     (18,250,869) $ (18,250,869)
Balance, ending at Jun. 30, 2021 $ 3,271 122,081,896 (61,809,471) $ 60,275,696
Balance, ending, shares at Jun. 30, 2021 32,716,827     32,716,827
Balance, beginning at Mar. 31, 2021 $ 2,317 77,082,072 (53,146,602) $ 23,937,787
Balance, beginning, shares at Mar. 31, 2021 23,180,024      
Stock-based compensation expense   625,182   625,182
Issuance of common stock, net of issuance costs $ 920 42,615,456   42,616,376
Issuance of common stock, net of issuance costs (in shares) 9,200,000      
Issuance of common stock, Vera acquisition $ 31 1,759,189   1,759,220
Issuance of common stock, Vera acquisition (in shares) 308,635      
Issuance of restricted stock for services (in shares) 2,692      
Exercise of stock options $ 3 (3)    
Exercise of stock options (in shares) 25,476      
Net loss     (8,662,869) (8,662,869)
Balance, ending at Jun. 30, 2021 $ 3,271 $ 122,081,896 $ (61,809,471) $ 60,275,696
Balance, ending, shares at Jun. 30, 2021 32,716,827     32,716,827